IL6 and inflammatory bowel disease: SpA patients with IBD had higher prevalence of HLA-B27 antigen (P = 0.04) and higher disease activity as assessed using the VAS (P = 0.03), CRP (P = 0.0009), and IL-6 (P = 0.0003).